Sage Journals: Discover world-class research

Abstract

Introduction:

Our objectives are to (1) describe the pathogens, site, timing and risk factors for acquired infection during neonatal and pediatric ECMO and (2) explore the association between acquired infection and mortality.

Methods:

Secondary analysis of prospective data collected by the Collaborative Pediatric Critical Care Research Network between December 2012 and September 2014. Clinical factors associated with acquired infection were assessed with multivariable Cox regression. Factors associated with mortality were assessed with logistic regression.

Results:

Of 481 patients, 247 (51.3%) were neonates and 400 (83.2%) received venoarterial ECMO. Eighty (16.6%) patients acquired one or more infections during ECMO; 60 (12.5%) patients had bacterial, 21 (4.4%) had fungal and 11 (2.3%) had viral infections. The site of infection included respiratory for 53 (11.0%) patients, bloodstream for 21 (4.4%), urine for 20 (4.2%) and other for 7 (1.5%). Candida species were most common. Median time to infection was 5.2 days (IQR 2.3, 9.6). On multivariable analysis, a greater number of procedures for ECMO cannula placement was independently associated with increased risk of acquired infection during ECMO (Hazard Ratio 2.13 (95% CI 1.22, 3.72), p<0.01) and receiving ECMO in a neonatal ICU compared to a pediatric or cardiac ICU was associated with decreased risk (Hazard Ratio pediatric ICU 4.25 (95% CI 2.20, 8.20), cardiac ICU 2.91 (95% CI 1.48, 5.71), neonatal ICU as reference, p<0.001). Acquired infection was not independently associated with mortality.

Conclusion:

ECMO procedures and location may contribute to acquired infection risk; however, acquired infection did not predict mortality in this study.

Keywords

extracorporeal membrane oxygenation infection pediatrics neonatal mortality

Get full access to this article

View all access options for this article.

References

Bizzarro

Conrad

Kaufman

et al . Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults. Pediatr Crit Care Med 2011; 12: 277–281.

Meyer

Jessen

Eberhart

RC.

Neonatal extracorporeal membrane oxygenation complicated by sepsis. Ann Thorac Surg 1995; 59: 975–980.

Douglass

Keenan

Purohit

et al . Bacterial and fungal infection in neonates undergoing venoarterial extracorporeal membrane oxygenation: an analysis of the registry data of the extracorporeal membrane life support organization. Artif Organs 1996; 20: 202–208.

Coffin

Bell

Manning

et al . Nosocomial infections in neonates receiving extracorporeal membrane oxygenation. Infect Control Hosp Epidemiol 1997; 18: 93–96.

Burket

Bartlett

Vander Hyde

et al . Nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation. Clin Infect Dis 1999; 28: 828–833.

O’Neill

Schutze

Heulitt

et al . Nosocomial infections during extracorporeal membrane oxygenation. Intensive Care Med 2001; 27: 1247–1253.

Kaczala

Paulus

Al-Dajani

et al . Bloodstream infections in pediatric ECLS: usefulness of daily blood culture monitoring and predictive value of biological markers. The British Columbia experience. Pediatr Surg Int 2009; 25: 169–173.

Schutze

Heulitt

MJ.

Infections during extracorporeal life support. J Pediatr Surg 1995; 30: 809–812.

Steiner

Stewart

Bond

et al . Predictors of acquiring a nosocomial bloodstream infection on extracorporeal membrane oxygenation. J Pediatr Surg 2001; 36: 487–492.

10.

Montgomery

Strotman

Ross

et al . Impact of multiple organ system dysfunction and nosocomial infections on survival of children treated with extracorporeal membrane oxygenation after heart surgery. Crit Care Med 2000; 28: 526–531.

11.

Biffi

Di Bella

Scaravilli

et al . Infections during extracorporeal membrane oxygenation: Epidemiology, risk factors, pathogenesis and prevention. Int J Antimicrob Agents 2017; 50: 9–16.

12.

Elerian

Sparks

Meyer

et al . Usefulness of surveillance cultures in neonatal extracorporeal membrane oxygenation. ASAIO 2001; 47: 220–223.

13.

Brown

Ridout

Shaw

et al . Healthcare-associated infection in pediatric patients on extracorporeal life support: the role of multidisciplinary surveillance. Pediatr Crit Care Med 2006; 7: 546–550.

14.

Dalton

Reeder

Garcia-Filion

et al . Factors associated with bleeding and thrombosis in children receiving extracorporeal membrane oxygenation (ECMO). Am J Respir Crit Care Med 2017; 196: 762–771.

15.

Gaies

Gurney

Yen

et al . Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med 2010; 11: 234–238.

16.

Gaies

Jeffries

Niebler

et al . Vasoactive-inotropic score is associated with outcome after infant cardiac surgery: an analysis from the Pediatric Cardiac Critical Care Consortium and Virtual PICU System Registries. Pediatr Crit Care Med 2014; 15: 529–537.

17.

Vogel

Lew

Kao

et al . Defining risk for infectious complications on extracorporeal life support. J Pediatr Surg 2011; 46: 2260–2264.

18.

Schmidt

Brechot

Hariri

et al . Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. Clin Infect Dis 2012; 55: 1633–1641.

19.

Wilson

Webster

Heidemann

et al . Diagnosis and treatment of ventilator-associated infection: review of the critical illness stress-induced immune suppression (CRISIS) prevention trial data. Pediatr Crit Care Med 2016; 17: 287–293.

20.

Tse-Chang

Midodzi

Joffe

et al . Infections in children receiving extracorporeal life support. Infect Control Hosp Epidemiol 2011; 32: 115–120.

21.

Hocker

Wellhausen

Ward

et al . Effect of extracorporeal membrane oxygenation on leukocyte function in neonates. Artif Organs 1991; 15: 23–28.

22.

Zach

Steinhorn

Georgieff

et al . Leukopenia associated with extracorporeal membrane oxygenation in newborn infants. J Pediatr 1990; 116: 440–444.

23.

Tajima

Yamamoto

Kawazoe

et al . Cardiopulmonary bypass and cellular immunity. Ann Thorac Surg 1993; 55: 625–630.

24.

Beurskens

Horn

deBoer

et al . Cardiac arrest patients have an impaired immune response, which is not influenced by induced hypothermia. Crit Care 2014; 18; R162.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.08 MB

Acquired infection during neonatal and pediatric extracorporeal membrane oxygenation